A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

A Phase 1, Two-Part Study of NIP292 Tablets in Healthy Adult Subjects: Part 1 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses; Part 2 - Randomized, Double-Blind, Placebo-Controlled Assessment of Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses.

This study is being conducted to evaluate the safety and tolerability of single ascending and multiple ascending oral doses of NIP292 tablets administered following an overnight fast in healthy adult subjects.

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

Recruitment

Summary

Participation Requirements

Description

Tracking Information